MedTrace Logo

Management of Postoperative Pain With Preemptive Analgesia in Cesarean Section

NCT02879435 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-08-25

No results posted yet for this study

Summary

This research will explore the question of whether preincisional skin infiltration with bupivacaine 0.25% decreases postoperative pain after Cesarean delivery.

Conditions

  • Labor Pain

Interventions

DRUG

Bupivacaine

pre-operative wound infiltration with 10 ml of numbing medicine

OTHER

Placebo

pre-operative wound infiltration with 10 ml of sterile water

Sponsors & Collaborators

  • Mark Kosanovich

    lead OTHER

Principal Investigators

  • Rohitkumar Vasa, MD · IRB Chair

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-12-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02879435 on ClinicalTrials.gov